School of Medicine


Showing 1-44 of 44 Results

  • Steven Adelsheim

    Steven Adelsheim

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioSteven Adelsheim, MD is a child/adolescent and adult psychiatrist who works to support community behavioral health partnerships locally, regionally, at the state level and nationally. He is the Director of the Stanford Center for Youth Mental Health and Wellbeing in the Department of Psychiatry. Dr. Adelsheim has partnered in developing statewide mental health policy and systems, including those focused on school mental health, telebehavioral health, tribal behavioral health programs, and suicide prevention. For many years Dr. Adelsheim has been developing and implementing early detection/intervention programs for young people in school-based and primary care settings, including programs for depression, anxiety, prodromal symptoms of psychosis, and first episodes of psychosis. Dr. Adelsheim is also involved in the implementation of integrated behavioral health care models in primary care settings as well as the use of media to decrease stigma surrounding mental health issues. He is currently leading the US effort to implement the headspace model of mental health early intervention for young people ages 12-25 based in Australia. Dr. Adelsheim also leads the national clinical network for early psychosis programs called PEPPNET.

  • Rania Awaad, MD

    Rania Awaad, MD

    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsAs the Director of the Muslims and Mental Health Lab, Dr. Awaad is dedicated to creating an academic home for the study of mental health as it relates to the Islamic faith and Muslim populations. The lab aims to provide the intellectual resources to clinicians, researchers, trainees, educators, community and religious leaders working with or studying Muslims.

  • Rebecca A. Bernert, PhD, ABPP, FT

    Rebecca A. Bernert, PhD, ABPP, FT

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioI am an Assistant Professor of Psychiatry and Behavioral Sciences and a licensed clinical psychologist in the Stanford University School of Medicine. I am a suicidologist, with subspecialty expertise in clinical trials, epidemiology, and suicide prevention best practices. I have joint specialty in behavioral sleep medicine, treatment development, and thanatology. I am Founding Director of The Stanford Suicide Prevention Research Laboratory, and Co-Chair a number of initiatives to support multidisciplinary efforts in suicide prevention. Our program utilizes cognitive, biological (e.g., fMRI), and behavioral testing paradigms, with an emphasis on translational therapeutics across the lifespan. Our mission is to identify novel therapeutics, including seminal work to establish the subfield of sleep and suicide prevention. A special focus is the development of rapid-action, low-risk interventions for the prevention of suicide. Our mission is to evaluate transdiagnostic risk factors and biomarkers underlying treatment response that may inform etiology, reduce stigma, and advance innovation. Advocating for its utility as a visible, yet non-stigmatizing warning sign of suicide—our earliest work delineated sleep as a risk factor for suicidal behaviors. Funded by NIH and DOD, we subsequently conducted the first suicide prevention clinical trials, testing efficacy of a rapid-action (6 h) insomnia treatment for suicidal behaviors. These use a mechanisms focus to identify central disease processes (eg, underlying neural circuitry, behavioral factors) for anti-suicidal response. An overarching aim is to harness new technologies to aid risk prediction, precision medicine, and intervention opportunity. We are committed to improving national training practices (e.g., national needs-assessment of medical training parameters; AI for suicide prevention), and lead hospital best practices for safety in screening, triage, and postvention.

    Regarding translation to policy, I have served as a content expert for nationally-directed health initiatives with NIH, VA, DOD, DARPA, SAMHSA, CDC, and The White House. I recently led development of the CA 2020-25 Statewide Strategy for Suicide Prevention, following invited testimony (CA State Assembly) and a commissioned Policy Brief on suicide prevention best practices. Advisory and advocacy work centers on how research guides public health policy and implementation. I am especially committed to initiatives promising impact to suicide prevention on a broad scale, including universal strategies for lethal means restriction and real-time surveillance of suicidal behaviors. To this end, I have been honored to serve as a content expert to The White House Office of Science and Technology for initiatives focused on technology innovation and led advisory work promoting suicide deterrent systems for private organizations and public sites, such as the Golden Gate Bridge. I have consulted for technology companies, as well as private industry and healthcare partners.

    Inspired by maternity leaves coinciding with the above work, I have a separate research line examining organizational development, inclusive practices, sleep and employee wellness. This addresses disparate impact of institutional and federal medical leave practices on recruitment and retention of women. Our program focuses on cost-effective policy for diversity training and reduced attrition of women in medicine, law, STEM and technology fields. As such, I am dedicated to spearheading development of a Stanford Center for Policy, Inclusive Practices, and Equity Education.

    To donate or partner with us, please contact Deborah Stinchfield (Stanford Medical Center Development) medicalgiving@stanford.edu or please contact us directly.

  • Christiane Brems, PhD, ABPP, ERYT500, C-IAYT

    Christiane Brems, PhD, ABPP, ERYT500, C-IAYT

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioChristiane Brems, PhD, ABPP, RYT-500, C-IAYT, is the Founding Director of YogaX, a Special Initiative in the Department of Psychiatry and Behavioral Science. She received her PhD in Clinical Psychology from Oklahoma State University in 1987. Dr. Brems is licensed as a psychologist in several US states and board-certified as a clinical psychologist by the American Board of Professional Psychology (ABPP). She is a registered yoga teacher (E-RYT500) and certified C-IAYT yoga therapist. She is also certified in Interactive Guided Imagery.

    She began her career in academia at the University of Oklahoma Health Sciences Center. She then served on faculty at the University of Alaska Anchorage for 23 years, where she held a variety of leadership positions, including as (Co-Founding) Director of the Center for Behavioral Health Research and Services, (Co-Founding) Director of the PhD Program in Clinical-Community Psychology, and Interim Vice Provost for Research and Dean of the Graduate School. Most recently, she served for nearly six years as Dean and Professor of the School of Graduate Psychology (SGP) at Pacific University Oregon.

    Dr. Brems has worked for decades as an applied researcher and clinical practitioner with particular interests in health promotion, rural healthcare delivery, and all things yoga. Her work has been funded by grants and contracts from the National Institutes of Health, the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Service Administration, and local and State of Alaska funding sources. She has shared her work extensively in over 120 peer-reviewed journal articles, 100s of technical reports, and several books, including the Comprehensive Guide to Child Psychotherapy (now in its 4th edition), Dealing with Challenges in Psychotherapy and Counseling, Basic Skills in Counseling and Psychotherapy, and others. Dr. Brems is committed to excellence in and integration of clinical services, teaching, consultation, and research.

    Dr. Brems has integrated yoga, mindfulness, complementary interventions, and self-care strategies in her work as a consultant, author, dean, teacher, researcher, mentor, supervisor, colleague, and service provider. She values these practices as crucial aspects of day-to-day professional and personal life and seeks to enhance access to them for all who can benefit.

  • Eve Carlson

    Eve Carlson

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioEve Carlson is a Clinical Professor who focuses on fostering mental health after traumatic stress. She is a clinical psychologist and a researcher with the National Center for Posttraumatic Stress Disorder’s Dissemination and Training Division. Her primary interests are in measurement development and recovery after traumatic stress. She collaborates with faculty in Surgery (David Spain) and Medicine (Lisa Shieh) to study mental health of patients hospitalized after sudden, severe illness or injury, racial/ethnic disparities in traumatic stress risks and responses, screening for risk of mental health problems, and preventive mental health care. As PIs of a multi-center study funded by the National Institute on Minority Health and Health Disparities, Dr. Carlson and Dr. Spain and their collaborators have developed and validated a mental health risk screen for hospital patients admitted after sudden, severe illness or injury. Data from patients who identify as Asian American/Pacific Islander, Black, Latinx, Multiracial, and White were analyzed to select screen items, and the screen accurately predicts later mental health outcomes within these ethnic/racial groups. Our research has also found disparities across ethnic/racial groups in several traumatic stress risk factors and mental health responses. Dr. Carlson is Co-PI with Dr. Shieh of a study funded by Stanford RISE comparing mental health recovery in Latinx and non-Latinx COVID-19 patients to recovery in patients hospitalized with other sudden, severe illness.

  • Timothy Durazzo

    Timothy Durazzo

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsThe mission of the Durazzo BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, our multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety. Veteran's Administration and Stanford funded Clinical trials are currently being conducted by the BRASS lab that evaluate repetitive transcranial magnetic stimulation techniques as novel complementary treatments to reduce the high rate of relapse experienced by individuals with alcohol and substance abuse disorders. The ultimate goal of our multidisciplinary research program is to promote the development of more effective biomedical and behavioral treatments for alcohol and substance use disorders through consideration of the brain biology, psychology and social circumstances of each individual.

  • Cheryl Gore-Felton, Ph.D.

    Cheryl Gore-Felton, Ph.D.

    Walter E. Nichols, MD Professor in the School of Medicine

    Current Research and Scholarly InterestsMy clinical focus is the treatment of anxiety disorders, including post traumatic stress disorder. My research focuses on developing effective psychotherapy interventions to reduce chronic stress as well as enhance positive health behaviors to reduce morbidity and mortality among patients coping with chronic, medical illnesses which are often life threatening.

  • Heather Gotham

    Heather Gotham

    Clinical Associate Professor, Psychiatry and Behavioral Sciences
    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Gotham’s research focuses on implementation science, including factors affecting implementation, and training and education of health care providers, across a range of evidence-based practices for adolescent and adult substance use and mental health disorders, co-occurring mental health and substance use disorders, and screening, brief intervention, and referral to treatment (SBIRT).

  • Laura Michele Hack

    Laura Michele Hack

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Laura Hack is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Director of Novel & Precision Neurotherapeutics at the Stanford Center for Precision Mental Health and Wellness, Director of the Stanford Translational Precision Mental Health Clinic, and Deputy Director of the Precision Neuromodulation Clinic (PNC) within the VA Palo Alto Health Care System. Dr. Hack's translational research program focuses on identifying bioclinical subtypes of depression and testing mechanistically-guided treatments for these subtypes. Dr. Hack studies treatments spanning repurposed medications, such as pramipexole and guanfacine, neuromodulation techniques, ketamine, MDMA, and psilocybin. Clinically, she specializes in delivering novel treatments, including repetitive transcranial magnetic stimulation (rTMS) and ketamine, to patients suffering from treatment-resistant depression and comorbid trauma-related disorders.

  • Kate Hardy

    Kate Hardy

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.

  • Keith Humphreys

    Keith Humphreys

    Esther Ting Memorial Professor

    Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.

  • Shaili Jain, MD

    Shaili Jain, MD

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Jain serves as a psychiatrist at the VA Palo Alto Health Care System. She is board certified in general psychiatry, with specialty expertise in posttraumatic stress disorder (PTSD), primary and mental health integrated care, and women’s health psychiatry. She is a health services researcher, affiliated with the National Center for PTSD, who focuses on developing innovative ways to enhance the reach of mental healthcare in underserved populations with PTSD. Her work is widely accredited for elucidating the role of paraprofessionals and peers in the treatment of American veterans with PTSD.

    Dr. Jain is an internationally recognized leader in communicating to the public about trauma and PTSD. Her posts for her Psychology Today blog on PTSD, In the Aftermath of Trauma, have been viewed over 250,000 times. Her acclaimed debut non-fiction trade book, The Unspeakable Mind: Stories of Trauma and Healing from the Frontlines of PTSD Science (Harper, 2019), was nominated for a National Book Award, and her essays and commentaries on trauma and PTSD have been presented by the BBC, CNN, The New York Times, STAT, Newsweek, The Los Angeles Times, TEDx, public radio, and others

  • Debra Lee Kaysen

    Debra Lee Kaysen

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)

    Current Research and Scholarly InterestsMuch of my current research focus is on the development of testing of accessible, scaleable, and effective treatments for trauma-related disorders and related comorbidities (e.g. substance use disorders, HIV, mood disorders). This work has focused on addressing trauma-related disorders especially in underserved populations and settings. This includes research in rural communities, with Native American communities, and with sexual minorities. My research has had a strong impact on building an evidence base on adaptations of psychotherapies for PTSD and substance use disorders for diverse populations both within and outside the United States. Our findings demonstrate that complex cognitive behavioral psychotherapies like Cognitive Processing Therapy can be culturally adapted and delivered in challenging settings (conflict settings, high poverty environments) with significant and lasting change in PTSD, depression, and functioning. This has led to work adapting CPT for diverse populations within the United States (rural Native Americans, urban Latinos) and outside of it (Iraq, DRC). Other research has focused on treatment for PTSD/SUD. My research has also found support for the use of brief telehealth interventions to build treatment engagement and to reduce drinking among trauma-exposed populations. In addition, my work has been critical in testing the feasibility of novel trauma-focused interventions for use by those with PTSD and SUD, thus paving the road for more rigorous research studies.

    Current PI'ed research studies include: 1) developing and evaluating a brief motivational interviewing intervention designed to increase treatment-seeking among military personnel with untreated PTSD; a two-arm randomized comparative effectiveness trial to evaluate prevention of HIV/STI sexual risk behavior by addressing PTSD through Narrative Exposure Therapy or substance use through Motivational Interviewing among Native American men and women with PTSD; and 3) a comparison of outcomes among patients randomized to initially receive pharmacotherapy or Written Exposure Therapy delivered in primary care as well as comparing outcomes among patients randomized to treatment sequences (i.e., switching and augmenting) for patients who do not respond to the initial treatment.

  • Corey Keller, MD, PhD

    Corey Keller, MD, PhD

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.

    We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders.

  • Christina Khan, MD, PhD

    Christina Khan, MD, PhD

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Christina Khan is a pediatric and adult psychiatrist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences. She specializes in the treatment of trauma, depression, anxiety, LGBTQ+ health, and physician wellness. Dr. Khan’s training includes doctoral and postdoctoral research training in community and public health, including specialized training in global health and PTSD research and treatment. Her work focuses on addressing health disparities in underserved populations and treating vulnerable and marginalized populations here in the United States and abroad.

    At Stanford, she is co-Chief of the Diversity and Cultural Mental Health Section in the Department of Psychiatry and Behavioral Sciences and founder and Director of THRIVE, Stanford's LGBTQ+ mental health clinic. She has been working with WellConnect since 2014 addressing burnout, trauma, and secondary trauma in Stanford physicians. Dr. Khan is also a Faculty Fellow at the Center for Innovation in Global Health (CIGH) and serves on the CIGH Program Leadership Committee.

    Nationally, Dr. Khan serves as Past President of the Association of Women Psychiatrists and as Councilor for the Council on Minority Mental Health and Health Disparities of the American Psychiatric Association.

  • Jane P. Kim

    Jane P. Kim

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Kim’s research focuses on applying statistical approaches to evaluate and improve digital interventions, and using empirical approaches to understand ethical considerations for AI applications in healthcare.

  • Steven Lindley

    Steven Lindley

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsMaximizing the use of evidence-based practices and reducing unnecessary medical burden of psychiatric treatments for stress-related disorders.

  • Mark McGovern

    Mark McGovern

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Mark McGovern is a Professor in the Department of Psychiatry & Behavioral Sciences and, by courtesy, the Department of Medicine at Stanford University School of Medicine.

    Most people who need health care do not receive it. And of those who do, wide variation exists in the quality of the care they receive. Gaps in health care access and quality are worse for certain groups, such as underrepresented minorities and persons living in low-resourced urban and rural areas, and/or in poverty. Enormous disparities exist in health care systems, both private and public. Dr. McGovern is a leader in using rigorous methods of dissemination and implementation (D&I) science to close these gaps in equitable health care delivery.

    His mission is to get the best health care possible to the people who need it the most.

    Dr. McGovern's primary focus is the implementation and sustainment of evidence-based interventions and guideline adherent care in public and private health care systems and organizations. Within the hub of the Center for Dissemination and Implementation (CDI) which he directs, Dr. McGovern is the Principal Investigator (PI) and leads three national dissemination and implementation (D&I) centers: The Center for Dissemination and Implementation At Stanford (C-DIAS); The Research Adoption Support Center (RASC); and, the Mental Health Technology Transfer Center Network Coordinating Center (MHTTC). The 3 centers are federally-funded, respectively by the National Institute on Drug Abuse (P50DA05402), the National Institutes of Health Healing Addiction Long Term (HEAL) initiative (U2CDA057717), and the US Department of Health and Human Services Substance Use and Mental Health Services Administration (H79SM081726). Dr. McGovern is also the PI on a multi-site adaptive implementation trial across a state system of care, which aims to integrate addiction medications for persons with opioid use disorder who are receiving services in specialty or primary care organizations (R01DA052975). In addition, he conducts D&I research and practice projects in federally-qualified health centers (FQHCs) across the State of California, in the Stanford Division of Primary Care and Population Health, and in specialty addiction and mental health treatment organizations nationwide. He leads, facilitates and/or actively engages networks advancing D&I science in health, including the NIDA Clinical Trials Network Translation & Implementation Special Interest Group, the NIDA Clinical Trials Western States Node Translation & Implementation Workgroup, the Stanford University Network for Dissemination & Implementation Research (SUNDIR), the VA Palo Alto HSR&D Center for Innovation to Implementation, and the Stanford Medicine Center for Improvement. He is on the Core Faculty of the National Institute of Mental Health Implementation Research Institute at the Washington University in St. Louis. Dr. McGovern is a collaborator on multiple projects as a co-investigator, consultant, or advisory board member. He is a mentor to numerous individuals across the country and at Stanford, from university undergraduates to mid-career faculty and clinical administrators at academic institutions and health care systems nationwide.

  • Kalpana Isabel Nathan

    Kalpana Isabel Nathan

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioKalpana Nathan, MD is an adjunct clinical professor, Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. After completion of residency and research fellowship at Stanford, she served 4 years at the San Francisco General Hospital/UCSF, gaining experience in the areas of substance use, HIV and public health. She worked at Palo Alto VA for more than a couple of decades. She served as chief medical director at Mental Health and Addiction services, El Camino Health for two and a half years, and is a certified physician executive. She has worked and taught in various settings, both inpatient and outpatient, as well as private and public sectors. She is board certified in General, Addiction and Forensic Psychiatry, as well as Lifestyle Medicine. Her interests include wellness and self-care for physicians, women's health, health creation and resiliency building for the community. She is a certified meditation teacher, has completed sprint and Olympic triathlons, and enjoys traveling around the world. She received the outstanding community clerkship preceptor award in 2010 and the Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine in 2015 at the Stanford University School of Medicine.

    Recent Publications:
    1. Tran BX, Nguyen TT, Boyer L, Fond G, Auquier P, Nguyen HSI,Ha Thi Nhi Tran HTN, Nguyen HM, Choi J, Le HT, Latkin CA, Nathan KI, Husain SF, et al: Differentiating people with schizophrenia from healthy controls in a developing country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool. Frontiers of Psychiatry 2023 Jan 26; vol 14

    2. Tatum, J, Nathan, K: The USA. Lancet Psychiatry 2021, 8(5):365-366

    3. Nathan N & Nathan KI: Suicide, Stigma, and Utilizing Social Media Platforms to Gauge Public Perceptions. Front. Psychiatry 2020 January 13

    4. Tran BX, Nathan KI, Phan HT, Hall BJ, Vu GT et al: A Global Bibliometric Analysis of Services for Children Affected by HIV/Acquired Immune Deficiency Syndrome: Implications for Impact Mitigation Programs (GAPRESEARCH). AIDS Rev. 2019 Oct 3;21(3).

    5.Lee A, Nathan KI: Understanding Psychosis in a Veteran With a History of Combat and Multiple Sclerosis. Fed Pract. 2019 Jun;36(Suppl 4):S32-S35.

    6. Tran BX, Ha GH, Vu GT, Nguyen LH, Latkin CA, Nathan K, McIntyre RS, Ho CS, Tam WW, Ho RC: Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis. Int J Environ Res Public Health. 2019 Jun 26;16(13)

  • Ruth O'Hara

    Ruth O'Hara

    Director, Spectrum, Senior Associate Dean, Research and Lowell W. and Josephine Q. Berry Professor

    Current Research and Scholarly InterestsDr. O'Hara's research aims to investigate how cognitive information processing deficits subserve affective symptoms in psychiatric disorders, and interact with key brain networks integral to these disorders. To do so, she has implemented a translational, interdisciplinary program that encompasses cellular models, brain and behavioral assays of affective and cognitive information processing systems in psychiatric disorders across the lifespan.

  • Karen Chan Osilla

    Karen Chan Osilla

    Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsDr. Osilla conducts health services research with a focus on delivering substance use services to underserved populations using innovative solutions that decrease health access disparities. Dr. Osilla has been conducting addictions research since 2006 and has been involved in clinical trials evaluating cognitive behavioral therapy, collaborative care, and motivational interviewing interventions (web and in-person) among youth, adult, military, family members, and other hard-to-reach populations.

  • Michael Ostacher

    Michael Ostacher

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Ostacher is Professor of Psychiatry and Behavioral Sciences. He is the Site Director for the Addiction Medicine Fellowship at the VA Palo Alto Health Care System, where he also serves as the Medical Director of the Pharmacology of Addiction Recovery Clinic, the Director of the Bipolar and Depression Research Program and the Co-Director of the VA/Stanford Exploratory Therapeutics Lab, the Director of Advanced Fellowship Training in Mental Illness Research and Treatment for MDs for the VISN 21 MIRECC, and the Site Director at the VA Palo Alto for Advanced Fellowship Training for Stanford. A graduate of Vanderbilt University School of Medicine, the Harvard School of Public Health, and Harvard Medical School, he completed his training at The Cambridge Health Alliance at Harvard Medical School in Adult Psychiatry, Public Psychiatry, and Geriatric Psychiatry, and is currently board certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine. He is the Digital Content Editor for the journal Evidence-Based Mental Health and is on the editorial boards of Bipolar Disorders, the International Journal of Bipolar Disorders, the Journal of Clinical Psychiatry, Current Psychiatry, and Psychiatric Annals. His current research includes roles as Site Investigator for VA-BRAVE, multicenter, randomized trial comparing long-acting injectable buprenorphine to sublingual buprenorphine/naloxone, and trials of psychedelic drugs in psychiatric disorders in Veterans. With funding from NIDA, he studied, along with Jaimee Heffner, Ph.D. at the Fred Hutchinson Cancer Research Center in Seattle, smoking cessation in people with bipolar disorder using a novel online psychotherapy derived from Acceptance and Commitment Therapy. His primary research interest is in large clinical trials mental health and addiction, and the implementation of evidence-based mental health practices.

  • Daryn Reicherter

    Daryn Reicherter

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Reicherter the director of the Human Rights in Trauma Mental Health Laboratory.

    He has expertise in the area of cross-cultural trauma psychiatry, having spent more than a decade dedicated to providing a combination of administrative and clinical services in trauma mental health locally and internationally. He is on the List of Experts for the Extraordinary Chambers in the Courts of Cambodia and for the United Nations’ International Criminal Court. He is on the Fulbright Specialists Roster for his work in international trauma mental health. He is a Senior Fellow at the Center for Innovations in Global Health at Stanford University. He has created and cultivated new clinical rotations for residency education and medical school education in the community clinics that he operates. And he has created new opportunities for resident, medical student, and undergraduate education in Global Mental Health.

    He has also been involved in the creation of clinical mental health programs for underserved populations in the San Francisco Bay Area. He is the Faculty Adviser for the Stanford’s Free Clinic Mental Health Program.

    After receiving degrees in Psychobiology and Philosophy from the University of California at Santa Cruz, Dr. Reicherter completed his doctorate in medicine at New York Medical College. He completed internship and residency and served as Chief Resident at Stanford University Hospitals and Clinics.

  • Carolyn Rodriguez

    Carolyn Rodriguez

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Carolyn Rodriguez is Associate Dean for Academic Affairs, Stanford University School of Medicine and a Consultation-Liaison Psychiatrist at the Palo Alto Veterans Affairs. As the Director of the Translational Therapeutics Lab and Professor in the Department of Psychiatry and Behavioral Sciences, Dr. Rodriguez leads studies investigating the brain basis of severe mental disorders. Her landmark clinical trials pioneer rapid-acting treatments for illnesses including Obsessive-Compulsive Disorder (OCD) and related disorders. Her NIH-, foundation-, and donor-funded mechanistic and clinical efficacy studies span targeted glutamatergic and opioid pathway pharmacotherapy, noninvasive brain stimulation, psychotherapy and suicide prevention. She is co-author of “Hoarding Disorder: A Comprehensive Clinical Guide,” published August 2022 by APA Publishing.

    Dr. Rodriguez also serves as Deputy Editor of The American Journal of Psychiatry, member of the Research Council of the American Psychiatric Association, member of Brain & Behavior Research Foundation Scientific Council, member of the American Foundation for Suicide Prevention Advisory Group, and Scientific and Clinical Advisory Board member of the International OCD Foundation. She has won several national awards, including the Presidential Early Career Award for Scientists and Engineers (PECASE). The PECASE recognizes investigators who are pursuing bold and innovative projects and is considered one of the highest honors in scientific research. Carolyn presented her research at the World Economic Forum in Davos and Fortune Brainstorm Health 2022 and her work has been highlighted by organizations including NPR, PBS, New York Times, ABC News, NBC News, Newsweek, Fortune, and Time.com. She contributes articles to Harvard Business Review and Huffington Post to share scientific findings with the public.

    Carolyn received her B.S. in Computer Science from Harvard University, followed by an M.D. from Harvard Medical School-M.I.T. and a Ph.D. in Neuroscience and Genetics from Harvard Medical School. Born in San Juan, Puerto Rico, she now lives with her husband and three children in Palo Alto.

  • Craig S. Rosen, Ph.D.

    Craig S. Rosen, Ph.D.

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsMy research aims at improving processes and outcomes of mental health care for veterans other people suffering from post-traumatic stress and other mental disorders.

    My primary focus is improving access to evidence-based treatments PTSD and other psychiatric disorders. My second emphasis is using telemedicine technologies to expand access to effective care. My third interest is measurement-based care, using ongoing data on patient progress to inform patients' and clinicians' decisions.

  • Fernanda Rossi, Ph.D.

    Fernanda Rossi, Ph.D.

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Rossi’s research focuses on developing, evaluating, and implementing assessment tools and interventions to improve the safety and mental health of individuals at risk of intimate partner violence, suicide, and drug overdose. She is particularly interested in using technology and clinical decision support tools to enhance the quality and implementation of intimate partner violence-, suicide-, and substance use-related care.

  • Logan Schneider

    Logan Schneider

    Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsFrom a research perspective, my long-term career plan is to refine the understanding of normal and dysfunctional sleep, much like the Epilepsy Phenome/Genome Project (EPGP) and Epi4K are doing for the enigmatic epilepsies. Insufficient sleep has been deemed a public health problem with poorly understood behavioral and physiologic sleep disorders lying at the core of the issue. I am currently using well-defined distinct and objective phenotypes (e.g. periodic limb movements, hypocretin-deficient narcolepsy) to acquire the analytic skills necessary to expand my knowledge of both signal processing and genetics, with the former enhancing my ability to identify and/or refine sleep phenotypes, and the latter facilitating the pathophysiological understanding of these phenotypes. As a consequence of a better link between symptoms/phenotypes, physiology, and genetic risks, more personally targeted and effective therapeutics can be developed to address the enriched spectrum of sleep disorders.

  • Eric Stice

    Eric Stice

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Stice served as an assistant professor and associate professor at the University of Texas at Austin and as a Senior Research Scientist at Oregon Research Institute before joining the faculty at Stanford University. His research focuses on identifying risk factors that predict onset of eating disorders, obesity, substance abuse, and depression to advance knowledge regarding etiologic processes, including the use of functional neural imaging. He also designs, evaluates, and disseminates prevention and treatment interventions for eating disorders, obesity, and depression. For instance, he developed a dissonance-based eating disorder prevention program that has been implemented with over 6 million young girls in 140 countries. He has published 335 articles in high-impact outlets, including Science, Psychological Bulletin, Archives of General Biological Psychiatry, American Journal of Clinical Nutrition, and Journal of Neuroscience.

  • Trisha Suppes, MD, PhD

    Trisha Suppes, MD, PhD

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsLong-term treatment strategies for bipolar disorder, treatment for bipolar II disorder, use of treatment algorithms, and treatment of major depression.

  • Dolores Gallagher Thompson, PhD, ABPP

    Dolores Gallagher Thompson, PhD, ABPP

    Professor (Research) of Psychiatry and Behavioral Science (Public Mental Health and Population Sciences), Emerita

    Current Research and Scholarly InterestsMy current research focuses on use of technology to improve mental health of older persons and their family members. I have a strong interest in how cultural diversity impacts mental health access, services, and outcomes. I am currently involved in several international research and demonstration projects in collaboration with the World Health Organization and the health care system in Thailand as well as projects in the US - notably, with rural caregivers and those of Asian American ancestry.

  • Ranak Trivedi

    Ranak Trivedi

    Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsEnhancing the role of informal caregivers in chronic disease self-management; assessment and treatment of mental illness in primary care settings; psychosocial antecedents and consequences of cardiovascular disease.

  • Nina Vasan, MD, MBA

    Nina Vasan, MD, MBA

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsMental illness is the greatest thief of human potential today. By harnessing the power of medicine, entrepreneurship, and technology, we can return that potential to the 2 billion people suffering around the world.

    Brainstorm is the world's first academic laboratory dedicated to transforming mental health through innovation and entrepreneurship.

  • Shannon Wiltsey Stirman

    Shannon Wiltsey Stirman

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsThe overarching goal of my program of research is to determine how to facilitate access to evidence-based psychosocial interventions (EBPs) in community and public sector mental health settings. Areas of emphasis include training and consultation, treatment fidelity and adaptation, AI and digital mental health interventions, and the identification of strategies that promote sustained implementation of EBPs.

  • Jerome Yesavage

    Jerome Yesavage

    Jared and Mae Tinklenberg Professor and Professor, by courtesy, of Neurology

    Current Research and Scholarly InterestsWe study cognitive processes and aging in our research center. Studies range from molecular biology to neuropsychology of cognitive processes.

  • Jong H. Yoon

    Jong H. Yoon

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)

    Current Research and Scholarly InterestsMy research seeks to discover the brain mechanisms responsible for schizophrenia and to translate this knowledge into the clinic to improve how we diagnose and treat this condition. Towards these ends, our group has been developing cutting-edge neuroimaging tools to identify neurobiological abnormalities and test novel systems-level disease models of psychosis and schizophrenia directly in individuals with these conditions.

    We have been particularly interested in the role of neocortical-basal ganglia circuit dysfunction. A working hypothesis is that some of the core symptoms of schizophrenia are attributable to impairments in neocortical function that results in disconnectivity with components of the basal ganglia and dysregulation of their activity. The Yoon Lab has developed new high-resolution functional magnetic resonance imaging methods to more precisely measure the function of basal ganglia components, which given their small size and location deep within the brain has been challenging. This includes ways to measure the activity of nuclei that store and control the release of dopamine throughout the brain, a neurochemical that is one of the most important factors in the production of psychosis in schizophrenia and other neuropsychiatric conditions.